April 2023
We were thrilled to have been a Gold sponsor at the SFB conference this year.
Our business manager, Patrick McDaniel, our Chief Scientific Officer, Anthony Bresin, our Innovation Project Manager, Mélanie Leroux, and our partner Echelon Biosciences were all in attendance, seeking opportunities to connect with other professionals in the field of Tissue Engineering & Regenerative Medicine.
To see our most recent news,
![](https://htlbiotech.com/wp-content/uploads/2023/08/partner-1.jpg)
Read more
news from us
-
Articles July 5, 2024
HTL Biotechnology Secures Medical Device Registration in China
Sodium DNA Raw Material Main Document (Polynucleotides) registered as a medical device (number M2024199-000) in China.
-
Articles June 21, 2024
HTL Biotechnology at CPHI China 2024
CPHI China is one of Asia’s leading Pharma events for trading and networking with 3,500+ exhibitors and 90,000+ professionals from the pharmaceutical industry,
-
Articles June 13, 2024
Discover our Quality Policy
At HTL Biotechnology, we believe in going beyond together to achieve the highest quality standards.